Canadian Precision Health Initiative (CPHI)
Supports precision health in Canada by building a national genome foundation for diagnosis and care innovation.
Genome Canada's Canadian Precision Health Initiative (CPHI) is a C$200 million national precision-health program announced in March 2025. Genome Canada contributes C$81 million, with the balance coming from industry, academic, and public-sector co-funders. The initiative is built to assemble Canada's largest human genomic database and sequence more than 100,000 genomes, while keeping Indigenous data sovereignty part of the design. It is a cooperative-agreement style program delivered through all six regional Genome Centres, with sequencing partners including Illumina, PacBio, and Oxford Nanopore Technologies. The structure is collaborative rather than open-ended: CPHI is about coordinated infrastructure, data generation, and partner delivery, not a recurring open competition with individual awards. The program spans research, health, and population-scale genomics. CPHI also sits beside Genome Canada's broader genomics stack, including the Pan-Canadian Genome Library and earlier health-genomics investments. Its appeal is for consortia that can work across regions and institutions, share data at scale, and build toward a national resource that can support precision-health work over time.
No upcoming rounds verified. Cadence: One-off.